LXRX logo

Lexicon Pharmaceuticals, Inc. (LXRX) Total Debt

Annual Total Debt:

$106.07M+$9000.00(+0.01%)
December 31, 2024

Summary

  • As of today, LXRX annual total debt is $106.07 million, with the most recent change of +$9000.00 (+0.01%) on December 31, 2024.
  • During the last 3 years, LXRX annual total debt has risen by +$103.79 million (+4554.37%).
  • LXRX annual total debt is now -57.04% below its all-time high of $246.88 million, reached on December 31, 2019.

Performance

LXRX Total Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLXRXbalance sheet metrics

Quarterly Total Debt:

$64.94M+$3.49M(+5.69%)
September 30, 2025

Summary

  • As of today, LXRX quarterly total debt is $64.94 million, with the most recent change of +$3.49 million (+5.69%) on September 30, 2025.
  • Over the past year, LXRX quarterly total debt has dropped by -$40.93 million (-38.66%).
  • LXRX quarterly total debt is now -73.71% below its all-time high of $247.01 million, reached on March 31, 2019.

Performance

LXRX Quarterly Total Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLXRXbalance sheet metrics

Total Debt Formula

Total Debt = Short Term Debt + Long Term Debt

LXRX Total Debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+0.0%-38.7%
3Y3 Years+4554.4%+112.0%
5Y5 Years-57.0%+211.1%

LXRX Total Debt Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Yearat high+4554.4%-38.9%+112.0%
5Y5-Year-57.0%+4554.4%-38.9%+2749.7%
All-TimeAll-Time-57.0%>+9999.0%-73.7%>+9999.0%

LXRX Total Debt History

DateAnnualQuarterly
Sep 2025
-
$64.94M(+5.7%)
Jun 2025
-
$61.45M(-42.2%)
Mar 2025
-
$106.26M(+0.2%)
Dec 2024
$106.07M(+0.0%)
$106.07M(+0.2%)
Sep 2024
-
$105.87M(+0.2%)
Jun 2024
-
$105.68M(-0.5%)
Mar 2024
-
$106.24M(+0.2%)
Dec 2023
$106.06M(+91.8%)
$106.06M(+0.1%)
Sep 2023
-
$106.00M(+0.4%)
Jun 2023
-
$105.55M(+89.9%)
Mar 2023
-
$55.59M(+0.5%)
Dec 2022
$55.29M(+2326.2%)
$55.29M(+80.5%)
Sep 2022
-
$30.63M(+20.5%)
Jun 2022
-
$25.42M(-0.4%)
Mar 2022
-
$25.52M(+1019.6%)
Dec 2021
$2.28M(-82.2%)
$2.28M(-84.0%)
Sep 2021
-
$14.20M(-0.9%)
Jun 2021
-
$14.32M(-0.5%)
Mar 2021
-
$14.40M(+12.4%)
Dec 2020
$12.81M(-94.8%)
$12.81M(-38.6%)
Sep 2020
-
$20.87M(-91.5%)
Jun 2020
-
$245.82M(-0.2%)
Mar 2020
-
$246.21M(-0.3%)
Dec 2019
$246.88M(+0.8%)
$246.88M(-0.0%)
Sep 2019
-
$246.89M(-0.0%)
Jun 2019
-
$246.95M(-0.0%)
Mar 2019
-
$247.01M(+0.8%)
Dec 2018
$245.00M(-0.3%)
$245.00M(+0.0%)
Sep 2018
-
$244.94M(-0.1%)
Jun 2018
-
$245.09M(-0.1%)
Mar 2018
-
$245.40M(-0.1%)
Dec 2017
$245.67M(+142.2%)
$245.67M(+145.3%)
Sep 2017
-
$100.14M(-0.4%)
Jun 2017
-
$100.54M(-0.5%)
Mar 2017
-
$101.02M(-0.4%)
Dec 2016
$101.45M(-1.4%)
$101.45M(-0.4%)
Sep 2016
-
$101.83M(-0.4%)
Jun 2016
-
$102.20M(-0.4%)
Mar 2016
-
$102.57M(>+9900.0%)
Dec 2015
$102.94M(-4.4%)
$0.00(-100.0%)
Sep 2015
-
$106.29M(-0.4%)
Jun 2015
-
$106.75M(-0.4%)
Mar 2015
-
$107.21M(-0.4%)
Dec 2014
$107.67M(+392.1%)
$107.67M(+422.4%)
Sep 2014
-
$20.61M(-2.0%)
Jun 2014
-
$21.04M(-2.0%)
Mar 2014
-
$21.46M(-1.9%)
Dec 2013
$21.88M(-6.7%)
$21.88M(-1.8%)
Sep 2013
-
$22.28M(-1.7%)
Jun 2013
-
$22.68M(-1.7%)
Mar 2013
-
$23.06M(-1.7%)
Dec 2012
$23.45M
$23.45M(-1.6%)
Sep 2012
-
$23.83M(-1.5%)
DateAnnualQuarterly
Jun 2012
-
$24.19M(-1.4%)
Mar 2012
-
$24.54M(-1.4%)
Dec 2011
$24.89M(-12.6%)
$24.89M(-1.4%)
Sep 2011
-
$25.24M(-1.3%)
Jun 2011
-
$25.57M(-9.3%)
Mar 2011
-
$28.20M(-1.0%)
Dec 2010
$28.48M(-57.5%)
$28.48M(-0.9%)
Sep 2010
-
$28.75M(-36.1%)
Jun 2010
-
$45.02M(-30.5%)
Mar 2010
-
$64.80M(-3.2%)
Dec 2009
$66.96M(+119.6%)
$66.96M(-1.0%)
Sep 2009
-
$67.61M(+1.0%)
Jun 2009
-
$66.97M(+49.1%)
Mar 2009
-
$44.92M(+47.3%)
Dec 2008
$30.49M(-2.8%)
$30.49M(-0.8%)
Sep 2008
-
$30.72M(-0.7%)
Jun 2008
-
$30.94M(-0.7%)
Mar 2008
-
$31.16M(-0.7%)
Dec 2007
$31.37M(-2.5%)
$31.37M(-0.7%)
Sep 2007
-
$31.58M(-0.6%)
Jun 2007
-
$31.79M(-0.6%)
Mar 2007
-
$31.98M(-0.6%)
Dec 2006
$32.19M(-12.9%)
$32.19M(-11.5%)
Sep 2006
-
$36.38M(-0.5%)
Jun 2006
-
$36.57M(-0.5%)
Mar 2006
-
$36.75M(-0.5%)
Dec 2005
$36.94M(-1.8%)
$36.94M(-0.5%)
Sep 2005
-
$37.12M(-0.5%)
Jun 2005
-
$37.29M(-0.4%)
Mar 2005
-
$37.45M(-0.5%)
Dec 2004
$37.63M(-33.2%)
$37.63M(-0.4%)
Sep 2004
-
$37.80M(-0.4%)
Jun 2004
-
$37.95M(-32.6%)
Mar 2004
-
$56.34M(0.0%)
Dec 2003
$56.34M(+1308.6%)
$56.34M(+1308.6%)
Sep 2003
-
$4.00M(0.0%)
Jun 2003
-
$4.00M(0.0%)
Mar 2003
-
$4.00M(0.0%)
Dec 2002
$4.00M(>+9900.0%)
$4.00M(>+9900.0%)
Sep 2002
-
$0.00(0.0%)
Jun 2002
-
$0.00(0.0%)
Mar 2002
-
$0.00(0.0%)
Dec 2001
$0.00(-100.0%)
$0.00(-100.0%)
Sep 2001
-
$526.80K(-45.9%)
Jun 2001
-
$974.40K(-62.7%)
Mar 2001
-
$2.61M(-8.3%)
Dec 2000
$2.85M(-40.4%)
$2.85M(-7.7%)
Sep 2000
-
$3.08M(-7.2%)
Jun 2000
-
$3.32M(-12.6%)
Mar 2000
-
$3.80M
Dec 1999
$4.78M(+266.7%)
-
Dec 1998
$1.30M(-75.3%)
-
Dec 1997
$5.27M(+6403.7%)
-
Dec 1996
$81.00K
-

FAQ

  • What is Lexicon Pharmaceuticals, Inc. annual total debt?
  • What is the all-time high annual total debt for Lexicon Pharmaceuticals, Inc.?
  • What is Lexicon Pharmaceuticals, Inc. annual total debt year-on-year change?
  • What is Lexicon Pharmaceuticals, Inc. quarterly total debt?
  • What is the all-time high quarterly total debt for Lexicon Pharmaceuticals, Inc.?
  • What is Lexicon Pharmaceuticals, Inc. quarterly total debt year-on-year change?

What is Lexicon Pharmaceuticals, Inc. annual total debt?

The current annual total debt of LXRX is $106.07M

What is the all-time high annual total debt for Lexicon Pharmaceuticals, Inc.?

Lexicon Pharmaceuticals, Inc. all-time high annual total debt is $246.88M

What is Lexicon Pharmaceuticals, Inc. annual total debt year-on-year change?

Over the past year, LXRX annual total debt has changed by +$9000.00 (+0.01%)

What is Lexicon Pharmaceuticals, Inc. quarterly total debt?

The current quarterly total debt of LXRX is $64.94M

What is the all-time high quarterly total debt for Lexicon Pharmaceuticals, Inc.?

Lexicon Pharmaceuticals, Inc. all-time high quarterly total debt is $247.01M

What is Lexicon Pharmaceuticals, Inc. quarterly total debt year-on-year change?

Over the past year, LXRX quarterly total debt has changed by -$40.93M (-38.66%)
On this page